Study type: Human research · Status: Verified against declared source
Recombinant human thymosin beta‐4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis
2021
Study scale: Thymosin beta‐4 (Tβ4), a 43‐amino acid peptide, is involved in multiple cellular responses and plays dual roles in antimicrobial and immune modulation (Park et al., 2021).
Abstract only: Open source record
Product or molecular entity relationships
- Thymosin Beta-4 (TB500): Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.
Plain-language verified summary
Question
Not reported in the reviewed source.
Methods
Not reported in the reviewed source.
Scale or participants
Thymosin beta‐4 (Tβ4), a 43‐amino acid peptide, is involved in multiple cellular responses and plays dual roles in antimicrobial and immune modulation (Park et al., 2021).
Key findings
Seborrheic dermatitis (SD) is a recurrent common inflammatory skin disease that affects all ethnic groups in all regions worldwide.
Limitations and uncertainty
Seborrheic dermatitis (SD) is a recurrent common inflammatory skin disease that affects all ethnic groups in all regions worldwide.
Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.